BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  Reata Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs

  Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter of 2022 and provided an update on the Company’s business operations and clinical development programs.

  November 8, 2022

   · 

  14 min read
• Genetown

  Orchard Therapeutics to Present at Multiple Investor Conferences in November 2022

  Orchard Therapeutics, a global gene therapy leader, announced that members of the management team will present at the following investor conferences.

  November 8, 2022

   · 

  2 min read
• Business

  Bio-Path Holdings to Announce Third Quarter 2022 Financial Results on November 15, 2022

  Bio-Path Holdings, Inc., (NASDAQ: BPTH) today announced that it will host a live conference call and audio webcast on Tuesday, November 15, 2022 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2022 and to provide a business overview.

  November 8, 2022

   · 

  1 min read
• Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

  Mereo BioPharma Group plc today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022 at 12:55pm GMT / 07:55am ET.

  November 8, 2022

   · 

  4 min read
• BioMidwest

  BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present at the Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022 , at 2:25 p.m. EST.

  November 8, 2022

   · 

  2 min read
• Business

  Liminal BioSciences to Report Third Quarter 2022 Financial Results on November 9, 2022

  Liminal BioSciences Inc. today announced that it plans to report its third quarter 2022 financial results after market close on November 9, 2022.

  November 8, 2022

   · 

  4 min read
• Business

  Fusion Pharmaceuticals Announces Third Quarter 2022 Financial Results and Clinical Program Updates

  Fusion Pharmaceuticals Inc. today announced financial results for the third quarter ended September 30, 2022 and provided an update on clinical and corporate developments.

  November 8, 2022

   · 

  12 min read
• Biotech Bay

  Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases

  Juvena Therapeutics, Inc. announced today that it has raised $41 million in an oversubscribed Series A, bringing its total funding to $50 million.

  November 8, 2022

   · 

  5 min read
• Business

  Novanta Announces Financial Results for the Third Quarter 2022

  Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2022.

  November 8, 2022

   · 

  29 min read
• Business

  Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device

  Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device.

  November 8, 2022

   · 

  4 min read